A dosimetric study of polyethylene glycol hydrogel in 200 prostate cancer patients treated with high-dose rate brachytherapy ± intensity modulated radiation therapy

Radiotherapy and Oncology

Volumn 111, Issue 1, 2014, Pages 126-131

  Strom, Tobin J ^a   Wilder, Richard B ^a   Fernandez, Daniel C ^a   Mellon, Eric A ^a   Saini, Amarjit S ^a   Hunt, Dylan C ^a   Pow Sang, Julio M ^a   Spiess, Phillipe E ^a   Sexton, Wade J ^a   Poch, Michael A ^a   Biagioli, Matthew C ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Gel; HDR; High dose rate; Prostate; Radiotherapy

Indexed keywords

MACROGOL; LEUPRORELIN; HYDROGEL; MACROGOL DERIVATIVE;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; DOSIMETRY; HUMAN; HUMAN TISSUE; HYDROGEL; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; TRANSRECTAL ULTRASONOGRAPHY; VERY ELDERLY; ANDROGEN DEPRIVATION THERAPY; ANTIBIOTIC PROPHYLAXIS; BODY MASS; CANCER PATIENT; CANCER RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; HIGH RISK PATIENT; INTERMEDIATE RISK PATIENT; TREATMENT PLANNING; ADMINISTRATION AND DOSAGE; ADVERSE EFFECTS; BLADDER; COMPUTER ASSISTED RADIOTHERAPY; DRUG EFFECTS; ECHOGRAPHY; INJECTION; PROCEDURES; PROSTATIC NEOPLASMS; RADIATION RESPONSE; RECTUM;

AGED; AGED, 80 AND OVER; BRACHYTHERAPY; HUMANS; HYDROGEL; INJECTIONS; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; PROSTATIC NEOPLASMS; RADIATION DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; RECTUM; TOMOGRAPHY, X-RAY COMPUTED; URINARY BLADDER;

EID: 84902166821     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2014.02.011     Document Type: Article

References (30)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Cancer J Clin 62 2012 10 29
2. P.J. Hoskin, A.M. Rojas, and P.J. Bownes et al. Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancer Radiother Oncol 103 2012 217 222
3. A.A. Martinez, J. Gonzalez, and H. Ye et al. Dose escalation improves cancer-related events at 10 years for intermediate- and high-risk prostate cancer patients treated with hypofractionated high-dose-rate boost and external beam radiotherapy Int J Radiat Oncol Biol Phys 79 2011 363 370
4. D.A. Kuban, L.B. Levy, and M.R. Cheung et al. Long-term failure patterns and survival in a randomized dose-escalation trial for prostate cancer. Who dies of disease? Int J Radiat Oncol Biol Phys 79 2011 1310 1317
5. M.J. Zelefsky, X. Pei, and J.F. Chou et al. Dose escalation for prostate cancer radiotherapy: predictors of long-term biochemical tumor control and distant metastases-free survival outcomes Eur Urol 60 2011 1133 1139
6. J.L. Mohler, A.J. Armstrong, and R.R. Bahnson et al. Prostate cancer, version 3.2012: featured updates to the NCCN guidelines J Natl Compr Canc Netw 10 2012 1081 1087
7. M. Ghilezan, A. Martinez, and G. Gustason et al. High-dose-rate brachytherapy as monotherapy delivered in two fractions within one day for favorable/intermediate-risk prostate cancer: preliminary toxicity data Int J Radiat Oncol Biol Phys 83 2012 927 932
8. K.O. Castle, K.E. Hoffman, and L.B. Levy et al. Is androgen deprivation therapy necessary in all intermediate-risk prostate cancer patients treated in the dose escalation era? Int J Radiat Oncol Biol Phys 85 2013 693 699
9. J. Huang, F.A. Vicini, and S.G. Williams et al. Percentage of positive biopsy cores: a better risk stratification model for prostate cancer? Int J Radiat Oncol Biol Phys 83 2012 1141 1148
10. I. Deutsch, M.J. Zelefsky, and Z. Zhang et al. Comparison of PSA relapse-free survival in patients treated with ultra-high-dose IMRT versus combination HDR brachytherapy and IMRT Brachytherapy 9 2010 313 318
11. R. Khor, G. Duchesne, and K.H. Tai et al. Direct 2-arm comparison shows benefit of high-dose-rate brachytherapy boost vs external beam radiation therapy alone for prostate cancer Int J Radiat Oncol Biol Phys 85 2013 679 685
12. R. Kotecha, Y. Yamada, and X. Pei et al. Clinical outcomes of high-dose-rate brachytherapy and external beam radiotherapy in the management of clinically localized prostate cancer Brachytherapy 12 2013 44 49
13. R.C. Susil, T.R. McNutt, and T.L. DeWeese et al. Effects of prostate-rectum separation on rectal dose from external beam radiotherapy Int J Radiat Oncol Biol Phys 76 2010 1251 1258
14. Novel A, Spinal adhesion barrier & sealant, System; 2008.
15. D. Vetterli, S. Thalmann, and F. Behrensmeier et al. Daily organ tracking in intensity-modulated radiotherapy of prostate cancer using an electronic portal imaging device with a dose saving acquisition mode Radiother Oncol 79 2006 101 108
16. R.J. Smeenk, E.N. van Lin, and P. van Kollenburg et al. Endorectal balloon reduces anorectal doses in post-prostatectomy intensity-modulated radiotherapy Radiother Oncol 101 2011 465 470
17. A. Villers, J.E. McNeal, and F.S. Freiha et al. Invasion of Denonvilliers' fascia in radical prostatectomy specimens J Urol 149 1993 793 798
18. E. Gez, S. Cytron, and R.B. Yosef et al. Application of an interstitial and biodegradable balloon system for prostate-rectum separation during prostate cancer radiotherapy: a prospective multi-center study Radiat Oncol 8 2013 96
19. G. Hatiboglu, M. Pinkawa, and J.P. Vallee et al. Application technique: placement of a prostate-rectum spacer in men undergoing prostate radiation therapy BJU Int 110 2012 E647 E652
20. D.Y. Song, K.K. Herfarth, and M. Uhl et al. A multi-institutional clinical trial of rectal dose reduction via injected polyethylene-glycol hydrogel during intensity modulated radiation therapy for prostate cancer: analysis of dosimetric outcomes Int J Radiat Oncol Biol Phys 87 2013 81 87
21. D.C. Weber, T. Zilli, and J.P. Vallee et al. Intensity modulated proton and photon therapy for early prostate cancer with or without transperineal injection of a polyethylen glycol spacer: a treatment planning comparison study Int J Radiat Oncol Biol Phys 84 2012 e311 e318
22. R.B. Wilder, G.A. Barme, and R.F. Gilbert et al. Cross-linked hyaluronan gel reduces the acute rectal toxicity of radiotherapy for prostate cancer Int J Radiat Oncol Biol Phys 77 2010 824 830
23. R.B. Wilder, G.A. Barme, and R.F. Gilbert et al. Cross-linked hyaluronan gel improves the quality of life of prostate cancer patients undergoing radiotherapy Brachytherapy 10 2011 44 50
24. P.J. Prada, J. Fernandez, and A.A. Martinez et al. Transperineal injection of hyaluronic acid in anterior perirectal fat to decrease rectal toxicity from radiation delivered with intensity modulated brachytherapy or EBRT for prostate cancer patients Int J Radiat Oncol Biol Phys 69 2007 95 102
25. P.J. Prada, H. Gonzalez, and C. Menendez et al. Transperineal injection of hyaluronic acid in the anterior perirectal fat to decrease rectal toxicity from radiation delivered with low-dose-rate brachytherapy for prostate cancer patients Brachytherapy 8 2009 210 217
26. F. Eckert, S. Alloussi, and F. Paulsen et al. Prospective evaluation of a hydrogel spacer for rectal separation in dose-escalated intensity-modulated radiotherapy for clinically localized prostate cancer BMC Cancer 13 2013 27
27. M. Pinkawa, M.D. Piroth, and R. Holy et al. Quality of life after intensity-modulated radiotherapy for prostate cancer with a hydrogel spacer. Matched-pair analysis Strahlenther Onkol 188 2012 917 925
28. J. Jiang, J. Ahn, and W.Y. Huang et al. Association of obesity with cardiovascular disease mortality in the PLCO trial Prev Med 57 2013 60 64
29. M. Sumitomo, J. Asakuma, and H. Yoshii et al. Anterior perirectal fat tissue thickness is a strong predictor of recurrence after high-intensity focused ultrasound for prostate cancer Int J Urol 17 2010 776 782
30. N. Patil, J. Crook, and E.P. Saibishkumar et al. The effect of obesity on rectal dosimetry after permanent prostate brachytherapy Brachytherapy 8 2009 218 222